Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kangji Medical Holdings Limited ( (HK:9997) ) has shared an announcement.
Kangji Medical Holdings Limited has announced a proposal for its privatization through a scheme of arrangement, which has been approved by the Scheme Shareholders and Independent Shareholders at the Court Meeting and EGM held on November 10, 2025. The approval includes the cancellation of Scheme Shares and issuance of new shares to the Offeror, Knight Bidco Limited, with the expected withdrawal of Kangji Medical’s shares from the Stock Exchange set for December 9, 2025. This move signifies a strategic shift in the company’s operational structure, potentially impacting its market positioning and shareholder dynamics.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited is a company incorporated in the Cayman Islands, operating within the medical industry. The company is primarily focused on providing medical devices and solutions, with a market focus likely on healthcare and medical sectors.
YTD Price Performance: 49.36%
Average Trading Volume: 4,602,932
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.69B
Find detailed analytics on 9997 stock on TipRanks’ Stock Analysis page.